Background: Arithmetic average values about disease burden across aging adults are often used in the absence of having reliable access to real life data. Those values however assume group homogeneity in characteristics such as age, sex, disease incidence rates, or costs. The question arises about how much the overall outcome results, like total disease management costs, obtained under those homogeneity assumptions may deviate from real-world population data that may manifest non-homogeneous distributions. Without being able to have easily access to those real-world data and for getting a good approximation of the deviations in outcome results, a calculation method is proposed that should also indicate which factor may have a dominant influence on the cost difference between homogeneous and non-homogeneous results. The method should help focus the research for obtaining more accurate information from real-world data in subsequent steps that better estimate control gain of infectious diseases through new interventions. Methods: The method explores, as the outcome measure to assess, the relative deviation in overall infection management costs measured with homogeneity versus non-homogeneity design in the datasets of aging adults. Population modelling is used with an Extended Sensitivity Analysis Plan (ESAP) that simulates non-homogeneous, but realistic, approximates of age-specific distributional spread in demography, infectious disease, and its severity in people aged > 65 years old over a 1-year period in univariant and multivariant assessments. Disease management costs are adjusted for 3 infection severity levels with increased differences between them using multiplication factors up to 20 times the initial unit cost. Results: The assumed full homogenous dataset systematically overestimates up to 10% the overall disease management cost in aging adults when compared with a group simulated with non-homogeneous, but realistic distributions for age, infection, severity, and cost, mainly due to the difference in the demographic age composition. However, overall costs of a proposed homogeneous condition tend to underestimate the spending of non-homogeneous conditions when the reference case has a partially homogeneous setup instead of a full condition or when the demographic age-change in the non-homogeneous condition evolves towards age-demographic homogeneity (same number of people at each age with increasing age), a likely evolution in the coming 15 to 30 years. Conclusion: Assessing the current cost burden of infectious diseases in aging adults must consider exact age-composition of the demography, the type of infection spread with severity levels in function of age and their cost differences between severity levels to avoid unrealistic cost estimates when assuming unreal homogeneous group conditions that could currently overestimate the real costs.
The Health and Social Care Act 2012 implemented the most central and divisive structural changes to the NHS since the service’s inception
Background: The Human Immunodeficiency Virus (HIV) has been a stigmatized illness as well as a medical condition. Attitudes toward HIV/AIDS testing have been shown to suggest an individual’s predisposition to test for HIV. The objectives of this study were to develop an instrument examining the attitudes towards HIV/AIDS by adapting and validating the HIV Antibody Testing Attitude Scale for use in HIV self-testing among young people in Nigeria.
Background: Epidemics are devastating as they cause mortality, and morbidity and are associated with a lot of stigma. Uganda experienced an outbreak of Ebola Virus Disease (EVD) for 4 months from September 2022 to January 2023. Ebola Virus, from the filoviridae family, is a highly contagious viral hemorrhagic infection with a mortality rate of up to 90%. Of 164 cases, 18 were health workers, of whom 7 died. Health professions students formed a part of these health workers, and are frontline providers in managing epidemics through community interventions such as prevention, preparedness, and emergency response. They are often involved in initial clinical care, and are also custodians of knowledge, availing a large workforce that can be leveraged amongst their non-medical communities. This project targeted prevention, preparedness, and response to the current and future EVD epidemics within Mbarara through capacity building and information sharing led by health professional students.
Long Covid is an ongoing health hazard to many patients who had an original Covid-19 diagnosis. Whilst there has been much debate about the phenotypic nature of the disease, the implications of these among differing populations is yet to be comprehensively reviewed. This is particularly important for low-to-middle-income countries such as Brazil, that have limited resources and infrastructure within their healthcare systems to manage patients long-term that have had Covid-19 and Long covid. Brazil have had to stare at the Covid abyss with over-crowding of their intensive care units that left their healthcare system in chaos. The ongoing long-Covid case numbers therefore are exacerbating an ongoing issue for patients, policy makers and healthcare professionals. In line with this, and the population density of Brazil, we have explored the prevalence of long-Covid in one of the largest municipalities in northeast Brazil to report active patient and clinical reported outcomes that would enable a better understanding of the next steps require to curb these issues to a manageable situation. Methods: We designed a two-step approach to demonstrate the wider implications of long-covid using a commentary and a retrospective, cross-sectional study using realworld data. Findings: In this commentary we highlight the current issues and potential barriers Brazil faces. We will follow this up with a retrospective, cross-sectional study using real world data to report on the prevalence of long covid within 1,600 patients.
Both stroke and smoking continue to be major public health crises in the United States, with stroke being the third and fourth leading cause of death among women and men, respectively. The goal of this review will be to provide clinicians a succinct overview regarding the epidemiology, economics, and biology of stroke in the setting of smoking and electronic cigarette use. Special attention will be given to the escalating public health crisis of electronic cigarette use, emphasizing mechanistic relationships of stroke and lung injury. Readers will be made aware of the need for continued scientific advancement and study regarding these relationships, as well as the need for improved governmental and public health efforts to curb these ongoing public health crises.
Zika virus has emerged as a public health crisis and is associated with a number of neurological deficits; however, only subsets of individuals who contract a Zika virus infection develop severe symptoms. The mechanism underlying Zika virus-induced neuropathogenesis is still poorly understood. Recent studies have implicated the host immune response as a key regulator in Zika virus neuropathology. Specifically, immune responses generated from previous flavi virus infection may contribute to antibody-dependent enhancement of Zika virus infection. Innate immunity may also play an important role for the broad array of individual symptomatic differences. Therefore, host immunity may serve as a therapeutic target to reduce Zika-associated neuropathogenesis.
Our objective was to determine self-reported psychological wellbeing of American Indians (AIs). Data are from two surveys, a) 218 adults from the 2011 - 2012 Mino Giizhigad study including Ojibwe adults in Minnesota and Wisconsin, and b) 146 AI women aged 15 - 35 years from the 2011 Sacred Journey study residing in the Pacific Northwest. Reports of AI mental wellness/positive mental health were on par with or higher than found in previous studies with non-AI samples despite simultaneously disparate rates of AI anxiety, depressive symptoms, and differential exposure to sociohistorical stressors. Results are a paradoxical mismatch between mental wellness and mental stressors consistent across two separate, diverse samples of AI adults.
Colorectal cancer (CRC) incidence rates and mortality have been decreasing in the United States. Currently, states in the South have the smallest reduction in CRC mortality. The trends of CRC incidence rates in Georgia in comparison to the United States have not been investigated. We analyzed age-adjusted incidence rates of CRC in Georgia and the United States from 2000 to 2012 using data from SEER 18 registries. Age-adjusted incidence rates (95% CI) were calculated as cases per 100,000 to the 2000 US Standard population. CRC incidence rates were calculated for groupings based on age at time of diagnosis, race, sex, and geographic location within Georgia. Incidence rates were higher in males compared to females in Georgia. In Georgians age 50-64, incidence rates were higher compared to the US, while those ages 65+ displayed lower incidence rates. Black Georgians age 50-64 generally exhibited higher incidence rates of CRC and lower rates of decrease in incidence compared to other races in Georgia. Asian/Pacific Islander females age 50-64 in Georgia exhibited an increasing trend in incidence rate. Whites and blacks Georgians age 50-64 displayed higher incidence rates compared to the US, while Asian/Pacific Islanders displayed lower incidence rates. Greater incidence rates of CRC in rural and Greater Georgia were seen across all races when compared to overall rates in Georgia. Efforts should be made to address disparities in Georgia based on race and geographic location. Increased screening by colonoscopy or fecal occult blood testing, reduction of risk factors and promotion of healthy lifestyles can reduce CRC incidence rates.
We evaluated a variety of methods to recover S. aureus from inanimate surfaces. Two contact agar plates and three swab sampling methods were tested on porous and non-porous surfaces and bar soap. The cost and ease of use of each method was also evaluated. S. aureus was recovered using all methods on both porous and non-porous surfaces. S. aureus could not be detected on three of four brands of soap.
